Jinrui medical Center in Laos belongs to Jinxin Fertility Group and was jointly founded by a leading team of assisted reproduction specialists.

Located in the Boten Special Economic Zone in Laos, Jinrui Medical Center is an international IVF hospital supported as a priority project by the Lao government.

Jinrui Medical Center provides Jinxin's standardized quality-control system, a streamlined care process, consultations with specialists from China and the United States, customized reproductive medicine plans and Chinese-language patient support.

Jinxin Fertility was listed on the Main Board of the Hong Kong Stock Exchange in June 2019, becoming a leading Chinese medical services stock in Hong Kong's capital market and the first listed assisted reproduction medical services company. It was named “Best IPO in China” in Hong Kong's 2019 market by The Asset.

As an international specialist assisted reproduction provider, Jinxin Fertility owns and operates Chengdu Xinan Gynecological Hospital, Shenzhen Zhongshan Urology Hospital, Wuhan Jinxin Hospital of Integrated Traditional Chinese and Western Medicine, Yunnan Jinxin Jiuzhou Hospital, Kunming Hewanjia Obstetrics and Gynecology Hospital and Hong Kong Assisted Reproduction Centre in China.

It also owns HRC Fertility in the United States and Jinrui Medical Center in Laos, making it one of China's largest private assisted reproduction medical groups with global reach.

Jinrui Medical Center has a senior specialist team, leading European and U.S. laboratory equipment and Jinxin Fertility Group's standardized quality-control processes. It has also formed an assisted reproduction alliance with established fertility centers in China and the United States.

Through telemedicine, the center provides multidisciplinary consultations across multiple sites, manages issues throughout treatment and supports implementation of the treatment plan.

Jinrui has introduced an advanced embryo monitoring and analysis system that reduces disturbance from repeatedly opening and closing incubators, providing a more stable environment for embryo development. Experienced embryologists use the system for continuous, dynamic observation from multiple points, improving the accuracy of oocyte and embryo development assessment and supporting implantation and pregnancy rates.

The center has comprehensive air purification, temperature and humidity control systems, along with a high-grade laminar-flow purification system in the laboratory. Air purification devices are installed throughout the laboratory and in all gamete- and embryo-related equipment to reduce exposure to volatile organic compounds and airborne particles.

All in vitro handling of gametes and embryos takes place in a Class 100 laminar-flow embryology laboratory, providing advanced, high-quality facilities for treatment.